Skip to content
glp1.howSign in

Fatigue and low energy during GLP-1 titration

Fatigue is a recognized GLP-1 side effect. Many people notice it early in treatment or after a dose increase, though trials haven't tracked its timing. It usually has causes you can find and fix, such as eating too little, dehydration, or ongoing GI symptoms.

Updated Sep 26, 2026Evidence-backed

Feeling unusually tired is a recognized GLP-1 side effect, and many people notice it early in treatment or after a dose increase. In the Zepbound (tirzepatide) weight-management trials, 5–7% of people on the drug reported fatigue, compared with 3% on placebo (DailyMed, Zepbound label, revised 8/2026 (external link)). It rarely has a single cause. Usually it's some mix of eating much less, GI side effects that disrupt sleep or nutrition, dehydration, and your body adjusting to a new metabolic state. Most of those you can identify and do something about.

What's usually behind it

Eating much less. If your appetite has dropped sharply, low energy is a fairly direct consequence, especially in the first weeks. A preliminary study of 387 adults on weekly GLP-1 medications found average intake of roughly 750 kcal/day, with fewer than one in ten meeting protein recommendations (Korus et al., Journal of Translational Medicine, 2026, DOI (external link)). Falling short on protein and micronutrients can leave you tired even when total calories seem reasonable; our guide on protein, fat, and carbohydrates covers what to aim for.

Dehydration, especially if you also have nausea, vomiting, or diarrhea (see our GI side effects overview).

Poor sleep from GI discomfort or from adjusting to a new eating and medication schedule.

Blood sugar changes, mainly if you also take diabetes medication (see our guide on GLP-1s with insulin or sulfonylureas).

What tends to help

Keep protein and a baseline of calories coming in even when you're not hungry, so intake doesn't fall further than it needs to. Drink steadily through the day instead of waiting until you're thirsty. Treat GI symptoms instead of putting up with them (see our guides on nausea and constipation), because ongoing discomfort feeds fatigue through poor sleep and poor appetite.

Time may help too. Fatigue hasn't been tracked week by week in trials, so there's no firm timeline. If it follows the same pattern as GI symptoms, which in the STEP 1 trial were mostly temporary and clustered around dose increases (Wilding et al., NEJM, 2021, DOI (external link)), fatigue tied to a recent dose increase may ease over the following weeks.

When fatigue needs a closer look

Talk to your prescriber if fatigue is severe, lasts well beyond the usual adjustment period, or comes with dizziness, a rapid heart rate, or significant weakness. It can point to eating too little, an electrolyte imbalance, or another problem that time alone won't fix. Our guide on talking to your doctor about side effects that aren't improving can help you raise it.

Study findings above are attributed to their authors and were located via PubMed.

This article is for general education and is not medical advice. Talk with your prescriber or care team about your own situation.

fatigueenergyside-effectstitration

Was this helpful?

Common questions

Questions people often ask about this topic.

  • Why am I so tired after starting a GLP-1 or increasing my dose?

    Fatigue is a recognized side effect (5–7% on tirzepatide vs 3% on placebo in its weight-management trials), and it rarely has one cause. It's usually a mix of eating much less, GI side effects disrupting sleep or nutrition, dehydration, and your body adjusting to a new metabolic state. Working out which of these applies to you shows what you can fix.

  • How long does GLP-1 fatigue last?

    There's no firm timeline, because trials haven't tracked fatigue week by week. If it follows the same pattern as GI symptoms, which cluster around dose increases and then settle, fatigue tied to a recent increase may ease over the following weeks. Fatigue that persists usually has a cause you can find, such as low intake, dehydration, or ongoing GI symptoms, so look into it instead of just pushing through.

  • What can I do to have more energy on a GLP-1?

    Keep protein and a baseline of calories coming in even when your appetite is low, drink steadily through the day instead of only when thirsty, and treat GI symptoms like nausea or constipation instead of putting up with them. Ongoing GI discomfort feeds fatigue through poor sleep and poor appetite.

  • When should I talk to my doctor about fatigue on a GLP-1?

    Raise it with your prescriber if fatigue is severe, lasts well beyond the usual adjustment period, or comes with dizziness, a rapid heart rate, or significant weakness. It can point to eating too little, an electrolyte imbalance, or another problem that needs more than time to resolve.

Evidence: For & Against

Both sides of the topic, so you can weigh the evidence yourself.

3Supporting

Revision history

Last updated · 7 revisions recorded.

Show what changed
  1. v7

    Summary rewritten; Body revised

  2. v6

    Evidence sources 2 → 3

  3. v5

    Common questions revised

  4. v4

    Summary rewritten; Body revised

  5. v3

    Body revised

  6. v2

    Body revised

  7. v1

    Existing article recorded at the start of version history

Improve this page

Community notes

Share helpful experiences and questions. Notes are reviewed before publication and do not replace medical advice.

Loading notes…

    New submissions are currently paused. Existing approved notes remain available.

    Related terms

    • Pharmacovigilance — The science and practice of detecting, assessing, and preventing adverse effects of medications once they are in real-world use, after clinical trials end.
    • Telogen effluvium — A temporary form of diffuse hair shedding that begins two to three months after a physical stressor — including rapid weight loss — pushes many hair follicles into their resting phase at once.
    • FAERS (FDA Adverse Event Reporting System, now AEMS) — The FDA's database of voluntary side-effect reports from patients, clinicians, and manufacturers, used to detect safety signals after a drug is on the market. In March 2026 it became part of the FDA Adverse Event Monitoring System (AEMS).
    • Lowest effective dose — The smallest dose of a medication that produces the intended benefit with tolerable side effects. It is a standard prescribing principle.

    Related guides

    • Gastric emptying on a GLP-1: how much slower, how long it lasts, and what it means for gastroparesis — GLP-1 medications slow the stomach, but the trials show the effect is smaller and fades more than most people assume, especially with the long-acting weekly drugs. This guide covers how much slower, whether it lasts, how gastric emptying is measured, how it differs from gastroparesis, and why the "food ferments in your stomach" claim has no evidence behind it.
    • Restarting a GLP-1 after a missed stretch: what each drug's label says about re-titration — Missed a few weeks of Wegovy, Zepbound, Ozempic, Trulicity, Saxenda, or a GLP-1 pill? Only four labels spell out when to restart at a lower dose: Wegovy injection after 2 missed weekly doses, Saxenda and Victoza after more than 3 days, and Foundayo after 7 missed daily doses. The rest are silent on long gaps. This by-drug reference separates what each label says from what's left to your prescriber, and explains why going straight back to your old dose is risky.